Relief Therapeutics Inc (OTCMKTS:RLFTF) Launches PKU GOLIKE(R) KRUNCH in Germany and Italy
Biopharmaceutical company, Relief Therapeutics Inc (OTCMKTS:RLFTF) on September 9, 2021, announced that APR Applied Pharma Research, the wholly owned subsidiary, has launched affiliates in Germany and Italy, PKU GOLIKE(R) KRUNCH, a convenient chewable tablet for the dietary management of phenylketonuria, a metabolic genetic disorder. Paolo Galfetti, Chief Executive Officer of APR and President of Relief Europe, said that the firm is addressing a vital need with flexible option for PKU….